Page last updated: 2024-10-21

3-aminobenzamide and Leukemia

3-aminobenzamide has been researched along with Leukemia in 3 studies

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pogrebniak, A1
Schemainda, I1
Pelka-Fleischer, R1
Nüssler, V1
Hasmann, M1
Yamadori, I1
Yoshino, T1
Kondo, E1
Cao, L1
Akagi, T1
Matsuo, Y1
Minowada, J1
Tentori, L1
Turriziani, M1
Franco, D1
Serafino, A1
Levati, L1
Roy, R1
Bonmassar, E1
Graziani, G1

Other Studies

3 other studies available for 3-aminobenzamide and Leukemia

ArticleYear
Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    European journal of medical research, 2003, Oct-22, Volume: 8, Issue:10

    Topics: 1-Naphthylamine; Adenosine Triphosphate; Alkylating Agents; Apoptosis; Benzamides; Cell Death; Cell

2003
Comparison of two methods of staining apoptotic cells of leukemia cell lines. Terminal deoxynucleotidyl transferase and DNA polymerase I reactions.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 1998, Volume: 46, Issue:1

    Topics: Antibodies, Monoclonal; Apoptosis; Benzamides; Cell Nucleus; Coloring Agents; Cytoplasm; Deoxyribonu

1998
Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds.
    Leukemia, 1999, Volume: 13, Issue:6

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Benzamides; Dacarbazine; DNA Glycosylases; DNA Ligases

1999